Search clinical trials for: capsaicin 8% patches (Qutenza)

Total 61 results

The University of Texas Health Science Center at...

Completed

Capsaicin 8% Patch for Spinal Cord Injury Neuropathic Pain (Capsaicin)

Neuropathic Pain | Spinal Cord Injuries

United States
NeurogesX

Completed

Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy

HIV Infections | Pain | Peripheral Nervous System Diseases
Nadine ATTAL

Terminated

Capsaicin Patches In Knee Osteoarthritis In Obese Patients (CHILI-OB)

Pain

France
Aalborg University

Completed

Is Nociceptive Processing Evoked by Heat Homeostatically Regulated: A Contact-heat Evoked Potentials Study

Healthy

Denmark
University of Florida

Completed

Spinal and Supra-Spinal Pain Mechanisms in Patients With Fibromyalgia

Pain | Fibromyalgia

United States
University of Rochester
United Therapeutics

Completed

The Qutenza Patch as Treatment for Disabling Treprostinil (Remodulin) Infusion Site Pain

Pulmonary Arterial Hypertension | Pulmonary Hypertension

United States
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire

Completed

Clinical Trial Assessing the Efficacy of Capsaicin Patch (Qutenza®) in Cancer Patients With Neuropathic Pain (CAPSONCO)

Neuropathic Pain

France
NHS Greater Glasgow and Clyde

Unknown

Pre-emptive Analgesia With Qutenza in Lower Limb Amputation

Neuropathic Pain | Lower Limb Amputation

United Kingdom
Hjalte Holm Andersen

Completed

Effects of High-concentration Topical Capsaicin on Histaminergic and Non-histaminergic Itch

Pruritus

Denmark
Medical University of Vienna
Astellas Pharma GmbH

Completed

Pain Thresholds Under High-dose Topical Capsaicin

Pain

Austria
University Hospital, Brest

Recruiting

Analgesic Effectiveness of Capsaicin 8% Cutaneous Patch in Children (CAPSAPED)

Chronic Pain | Neuropathic Pain

France
NHS Greater Glasgow and Clyde

Unknown

Qutenza (Topical Capsaicin 8%) for Painful Arteriovenous Fistulae

Neuropathic Pain | Arteriovenous Fistulae

United Kingdom
Astellas Pharma Inc

Completed

A Study to Evaluate Efficacy and Safety of a Single Application of Capsaicin 8%Transdermal Delivery System Compared to Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN) (STEP)

Pain | Diabetic Peripheral Neuropathy

United States
Emma Aitken

Unknown

Qutenza for Critical Ischaemia in End Stage Renal Failure

Neuropathic Pain | End Stage Renal Failure

United Kingdom
Averitas Pharma, Inc.

Recruiting

Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery

Post Surgical Neuropathic Pain

United States, Spain, France, Netherlands, Poland, United Kingdom
Nantes University Hospital

Recruiting

Study Evaluating the Analgesic Efficacy of Capsaicin 8% Patches in Chronic Coccygodynia. (CAPSACOX)

Neuropathic Pain | Coccyx Disorder | Coccygodynia

France
Astellas Pharma Inc

Completed

A Study to Evaluate the Long-term Safety of Repeated QUTENZA Administration for Treatment of Pain Caused by Nerve Damage in Diabetic Patients (PACE)

Painful Diabetic Peripheral Neuropathy (PDPN)

Belgium, Czech Republic, France, Germany, Italy, Netherlands, Poland, Russian Federation, Spain, Ukraine, United Kingdom
Rigshospitalet, Denmark

Terminated

Capsaicin Patch 8 % for the Treatment of Persistent Pain After Inguinal Herniotomy

Persistent Pain After Inguinal Herniotomy

Denmark
Institut Toulousain d'Ostéopathie
Institut Claudius Regaud

Recruiting

Algology in Oncology Osteopathic Support (ALGOS) (ALGOS)

Breast Cancer | Neuropathic Pain

France
Imperial College London
United Therapeutics

Completed

Qutenza®-Remodulin® in Pulmonary Arterial Hypertension Patients

Pain | Pulmonary Hypertension

United Kingdom
Aalborg University
European Commission; Danish National Research Foundation

Completed

Measuring and Modulating Changes in EEG Resting State Functional Connectivity During Short-term and Long-term Pain

Prolonged Pain, EEG, Resting State Functional Connectivity

Denmark
Nantes University Hospital

Not yet recruiting

Analgesic Efficacy of Capsaicin 8% Patch (QUTENZA®) in Coccygodygnia (CAPSACOXp)

Coccyx Disorder
Astellas Pharma Inc

Completed

Method of Pre-treatment for Application of QUTENZA Capsaicin 8% Patch (LIFT)

or Peripheral Nerve Injury (PNI) | Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN)

Belgium, Czechia, Denmark, Ireland, Norway, Slovakia, United Kingdom
Astellas Pharma Inc

Completed

Safety and Effectiveness of Repeated Administration of QUTENZA Patches for Treatment of Pain Caused by Nerve Damage (STRIDE)

Neuralgia, Postherpetic

France, Italy, Spain, Austria, Ireland, Belgium, United Kingdom, Romania, Slovenia, Greece, Czechia, Finland, Poland, Netherlands, Hungary, Slovakia
Children's Hospital of Michigan

Completed

Sickle Cell Pain: Intervention With Capsaicin Exposure (SPICE)

Sickle Cell Disease | Neuropathic Pain

United States
Astellas Pharma Europe Ltd.

Completed

Observation of the Use of QUTENZA™ in Standard Clinical Practice (ASCEND)

Peripheral Neuropathic Pain

Austria, Greece, Italy, Portugal, Spain, Switzerland, United Kingdom
Brugmann University Hospital

Recruiting

Retrospective Analysis of capsaïcin Patch in Complex Regional Pain Syndrome

Complex Regional Pain Syndromes

Belgium
Samyang Biopharmaceuticals Corporation

Completed

Study of Capsaicin Patch for the Management of Peripheral Neuropathic Pain

Postherpetic Neuralgia | Peripheral Nerve Injury

Korea, Republic of
Corporacion Parc Tauli

Completed

The Efficacy and Safety Profile of Capsaicin 8% Patch Versus 5% Lidocaine Patch in Males With Diabetic Neuropathy

Diabetic Neuropathy | Diabetic Nerve Problems | Diabetic Complications Neurological

Pakistan
Astellas Pharma s.r.o.

Completed

A Study of Efficacy and Safety of Qutenza in Patients With Post-operative Peripheral Neuropathic Pain

Post-operative Peripheral Neuropathic Pain

Czech Republic
Institut Claudius Regaud

Recruiting

Study to Evaluate the Interest of Qutenza in Patients With Head and Neck Cancer in Remission and With Sequelae Neuropathic Pain. (TEC-ORL)

Head and Neck Cancer

France
Winston Laboratories

Completed

Civamide Patch Safety, Tolerability and PK Study

Healthy Volunteers

United States
Winston Laboratories

Completed

Evaluation of Civamide Patch in Treatment of Postherpetic Neuralgia and Post-Incisional Neuralgia

Postherpetic Neuralgia

United States, Canada
Kyunghee University Medical Center

Unknown

Efficacy of Topical Capsaicin on Chronic Neck Pain

Chronic Neck Pain

Korea, Republic of
NeurogesX

Completed

NGX-4010 for the Treatment of Postherpetic Neuralgia

Pain | Peripheral Nervous System Diseases | Neuralgia | Herpes Zoster | Shingles

United States
NeurogesX

Completed

Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy

HIV Infections | Pain | Peripheral Nervous System Diseases

United States
NeurogesX

Terminated

Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy

HIV Infections | Pain | Peripheral Nervous System Diseases

United States
NeurogesX

Completed

Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN)

HIV Infections | Pain | Peripheral Nervous System Diseases | Neuralgia | Herpes Zoster
Centre Hospitalier Universitaire de Besancon

Terminated

A Study of the Effects of Topical Capsaicin in the Treatment of Provoked Vestibulodynia (CAPSIVU)

Vestibulodynia

France
NeurogesX

Completed

Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain

Pain | Peripheral Nervous System Diseases | Neuralgia | Herpes Zoster

United States
NeurogesX

Completed

Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia

Pain | Peripheral Nervous System Diseases | Neuralgia | Herpes Zoster

United States
NeurogesX

Unknown

Pilot Study of High-Concentration Capsaicin Patches in the Treatment of Painful HIV-Associated Neuropathy

HIV Infections

United States
NeurogesX

Terminated

An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain

HIV Infections | Pain | Diabetes Mellitus | Diabetic Neuropathies | Peripheral Nervous System Diseases | Neuralgia | Herpes Zoster | Polyneuropathies
NeurogesX

Completed

Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain

HIV Infections | Pain | Diabetes Mellitus | Diabetic Neuropathies | Peripheral Nervous System Diseases | Neuralgia | Herpes Zoster | Polyneuropathies

United States
Yonsei University

Completed

Comparison of NSAID Patch Given in Monotherapy and NSAID Patch in Combination With Transcutaneous Electric Nerve Stimulation, Heating Pad, or Topical Capsaicin in the Treatment of Patients With Myofascial Pain Syndrome of the Upper Trapezius: A Pilot Study

Myofascial Pain Syndrome of the Upper Trapezius

Korea, Republic of
Yonsei University

Not yet recruiting

A Clinical Trial to Evaluate the Detection of Atrial Fibrillation for an One Day Versus More Than or Equal to Eight Days Using MEMO Patch PLUS in Individuals Aged ≥ 75 Years, or Those at High Risk of Stroke (MEMO-DAF8)

Atrial Fibrillation/Flutter in Patients With High Risk of Stroke

Korea, Republic of
Instituto Mexicano del Seguro Social
Centenario Hospital Miguel Hidalgo

Completed

Capsaicin for Cerebral Perfusion Augmentation (CCPA)

Cerebral Circulatory Disorder

Mexico
University Hospital, Antwerp

Terminated

Localized Neuropathic Pain: Topical Treatment Versus Systemic Treatment (PELICAN)

Neuropathic Pain

Belgium
Centrexion Therapeutics

Completed

A Study to Compare Levels of Capsaicin After Intra-Articular Injection and Topical Application in Patients With Painful Knee Osteoarthritis

Knee Osteoarthritis

United States
Byung-Sik Cho

Completed

Family-mismatched/Haploidentical Donors Versus Matched Unrelated Donors

Acute Myeloid Leukemia

Korea, Republic of

Search clinical trials for: capsaicin 8% patches (Qutenza)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations